We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 36 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. プレシジョン・システム・サイエンス Chiba//Pharmaceuticals and Biotechnology
  3. null/null
  4. 4 Tohoku Techno Arch Co., Ltd. Miyagi//Educational and Research Institutions
  5. 5 バイオマテックジャパン Hokkaido//Pharmaceuticals and Biotechnology
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

  1. Reagent for Fully Automatic Nucleic Acid Extraction Device MagDEA Dx SV プレシジョン・システム・サイエンス
  2. Pharmaceutical CDMO services 大塚化学
  3. Ouchi Shinko Chemical Industry Co., Ltd. 須賀川市 経済環境部商工課
  4. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  5. 4 Natural Proteoglycan, the Herbal Medicine of the Sea バイオマテックジャパン

medicine Product List

526～540 item / All 600 items

Displayed results
[Research Material] Global Market for Oral Diabetes Medications

[Research Material] Global Market for Oral Diabetes Medications

Global Market for Oral Diabetes Medications: Sulfonylureas, Meglitinides, Alpha-Glucosidase Inhibitors, Hospitals, Clinics, Others

This research report (Global Oral Antidiabetic Drugs Market) investigates and analyzes the current status and outlook for the global market of oral diabetes medications over the next five years. It includes information on the overview of the global oral diabetes medication market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oral diabetes medication market focus on sulfonylureas, meglitinides, and alpha-glucosidase inhibitors, while the segments by application target hospitals, clinics, and others. The regional segments calculate the market size of oral diabetes medications by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in oral diabetes medications, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for H3N2 Infection Treatment

[Research Material] Global Market for H3N2 Infection Treatment

Global Market for H3N2 Infection Treatment: APP-309, Aspidasept, C-05, CR-8020, Others, Clinics, Hospitals, Others

This research report (Global H3N2 Infection Treatment Market) investigates and analyzes the current state and outlook for the global market for H3N2 infection treatment over the next five years. It includes information on the overview of the global H3N2 infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the H3N2 infection treatment market include APP-309, Aspidasept, C-05, CR-8020, and others, while the segments by application include clinics, hospitals, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for H3N2 infection treatment. The report also includes the market share of major companies in H3N2 infection treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Hemorrhagic Stroke Treatment

[Research Material] The Global Market for Hemorrhagic Stroke Treatment

Global Market for Hemorrhagic Stroke Treatment: Antihypertensives, Anticoagulants, Antiepileptics, Others, Hospitals, Clinics, Surgical Clinics, Others

This research report (Global Hemorrhagic Stroke Treatment Market) investigates and analyzes the current state and outlook for the global market for hemorrhagic stroke treatment over the next five years. It includes information on the overview of the global hemorrhagic stroke treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the hemorrhagic stroke treatment market include antihypertensives, anticoagulants, anticonvulsants, and others, while the segments by application include hospitals, clinics, surgical clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for hemorrhagic stroke treatment. It also includes the market share of major companies in hemorrhagic stroke treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Acute Excitement and Aggression

[Research Material] The Global Market for Treatment of Acute Excitement and Aggression

Global Market for Acute Excitement and Aggression Treatment: Oral, Intramuscular Injection, Others, Hospitals & Outpatient Surgery Rooms, Psychiatric Medical Facilities, Others

This research report (Global Acute Agitation and Aggression Treatment Market) investigates and analyzes the current state and outlook for the global market for acute agitation and aggression treatment over the next five years. It includes information on the overview of the global acute agitation and aggression treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include oral, intramuscular injection, and others, while the segments by application focus on hospitals & outpatient surgical centers, psychiatric medical facilities, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acute agitation and aggression treatment. The report also includes the market share of major companies in the acute agitation and aggression treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Cardiovascular Disease Treatment Drugs

[Research Material] Global Market for Cardiovascular Disease Treatment Drugs

World Market for Cardiovascular Disease Treatments: Heparin, Coumadin, Sectral, Zebeta, Lopressor, Toprol-XL, Norvasc, Lot...

This research report (Global Cardiovascular Disease Drugs Market) investigates and analyzes the current state and outlook for the global market of cardiovascular disease treatment drugs over the next five years. It includes information on the overview of the global cardiovascular disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include heparin, coumadin, sectral, zebeta, lopressor, toprol-XL, norvasc, lotrel, and others, while the segments by application cover ischemic heart disease, dyslipidemia, stroke, thrombosis, atherosclerosis, coronary artery disease, peripheral artery disease, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for cardiovascular disease treatment drugs. It also includes the market share of major companies in the cardiovascular disease treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Radioimmunotherapy

[Research Material] Global Market for Radioimmunotherapy

World Market for Radioimmunotherapy: Non-Hodgkin Lymphoma (NHL), Follicular Lymphoma, Solid Tumors, Breast Cancer, Ovarian Cancer, Osteosarcoma, Neuroblastoma, ...

This research report (Global Radioimmunotherapy Market) investigates and analyzes the current status and outlook for the global radioimmunotherapy market over the next five years. It includes information on the overview of the global radioimmunotherapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the radioimmunotherapy market focus on non-Hodgkin lymphoma (NHL), follicular lymphoma, solid tumors, breast cancer, ovarian cancer, osteosarcoma, neuroblastoma, and prostate cancer, while the segments by application target tumor antigens, radioactive isotopes, and antibodies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of radioimmunotherapy. It also includes the market share of major companies in radioimmunotherapy, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Opioid-Induced Constipation Treatment Drugs

[Research Material] Global Market for Opioid-Induced Constipation Treatment Drugs

Global Market for Opioid-Induced Constipation Treatments: Lubiprostone, Methyl Naltrexone Bromide, Naldemedine, Alvimopan, Others, Hospitals ...

This research report (Global Opioid Induced Constipation Drugs Market) investigates and analyzes the current status and outlook for the global market of opioid-induced constipation treatment drugs over the next five years. It includes information on the overview of the global opioid-induced constipation treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include lubiprostone, methylnaltrexone bromide, naldemedine, alvimopan, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for opioid-induced constipation treatment drugs. It also includes the market share of major companies in the opioid-induced constipation treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Body Tinea Treatment Drugs

[Research Material] Global Market for Body Tinea Treatment Drugs

Global Market for Body Tinea Treatment Drugs: Antifungals, Steroids, Combination of Antimicrobials, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Tinea Corporis Drugs Market) investigates and analyzes the current status and outlook for the global market of tinea corporis treatment drugs over the next five years. It includes information on the overview of the global tinea corporis treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include antifungal agents, steroids, and combinations of anti-infectives, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for tinea corporis treatment drugs. It also includes the market share of major companies in the tinea corporis treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Triple-Negative Breast Cancer Treatment

[Research Material] The Global Market for Triple-Negative Breast Cancer Treatment

Global Market for Triple-Negative Breast Cancer Treatment: Alkylating Agents, Plant Products, Microbial Products, Metabolic Antagonists, Microtubule Stabilizers, Hospital Pharmacies, Retail Pharmacies

This research report (Global Triple-Negative Breast Cancer Treatment Market) investigates and analyzes the current state and future outlook of the global market for triple-negative breast cancer treatment over the next five years. It includes information on the overview of the global triple-negative breast cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the triple-negative breast cancer treatment market include alkylating agents, plant products, microbial products, metabolic antagonists, and microtubule stabilizers, while the segments by application focus on hospital pharmacies and retail pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for triple-negative breast cancer treatment. It also includes the market share of major companies in triple-negative breast cancer treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Papaverine Hydrochloride Injection

[Research Material] Global Market for Papaverine Hydrochloride Injection

World Market for Papaverine Hydrochloride Injection: 30mg/mL, 120mg/10mL, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Papaverine Hydrochloride Injection Market) investigates and analyzes the current status and outlook for the global market of papaverine hydrochloride injection over the next five years. It includes information on the overview of the global papaverine hydrochloride injection market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on 30mg/mL and 120mg/10mL, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size of papaverine hydrochloride injection by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the papaverine hydrochloride injection market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Vaginitis Treatment Drugs

[Research Material] Global Market for Vaginitis Treatment Drugs

Global Market for Vaginitis Treatment Drugs: Rx, OTC, Hospitals, Pharmacies, Others

This research report (Global Vaginosis Drug Market) investigates and analyzes the current state and outlook for the global market for vaginitis treatment drugs over the next five years. It includes information on the overview of the global vaginitis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the vaginitis treatment drug market focus on Rx and OTC, while the segments by application target hospitals, pharmacies, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for vaginitis treatment drugs. It also includes the market share of major companies in the vaginitis treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Paget's Disease Treatment

[Research Material] Global Market for Paget's Disease Treatment

World Market for Paget's Disease Treatment: Bisphosphonates, Calcitonin Analogues (Salmon Calcitonin), Analgesics, Calcium and Vitamin ...

This research report (Global Paget's Disease Treatment Market) investigates and analyzes the current status and outlook for the global market for Paget's disease treatment over the next five years. It includes information on the overview of the global Paget's disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Paget's disease treatment market include bisphosphonates, calcitonin analogs (salmon calcitonin), analgesics, and calcium and vitamin D supplements, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Paget's disease treatment. It also includes the market share of major companies in Paget's disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Progressive Relapsing Multiple Sclerosis

[Research Material] Global Market for Treatment of Progressive Relapsing Multiple Sclerosis

Global Market for Treatment of Progressive Relapsing Multiple Sclerosis: COG-133, GZ-402668, Inebilizumab, VCE-0032, Others, etc.

This research report (Global Progressive Relapsing Multiple Sclerosis Tr) investigates and analyzes the current state and outlook for the global market for progressive relapsing multiple sclerosis treatment over the next five years. It includes information on the overview of the global progressive relapsing multiple sclerosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the progressive relapsing multiple sclerosis treatment market include COG-133, GZ-402668, Inebilizumab, VCE-0032, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for progressive relapsing multiple sclerosis treatment. It also includes the market share of major companies in progressive relapsing multiple sclerosis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Toxoplasmosis Treatment Drugs

[Research Material] Global Market for Toxoplasmosis Treatment Drugs

Global Market for Toxoplasmosis Treatment Drugs: Injections, Tablets, Others, Chronic Toxoplasmosis Treatment, Acute Toxoplasmosis Treatment, Others

This research report (Global Drugs for Toxoplasmosis Market) investigates and analyzes the current status and outlook for the global market of toxoplasmosis treatment drugs over the next five years. It includes information on the overview of the global toxoplasmosis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include injections, tablets, and others, while the segments by application focus on chronic toxoplasmosis treatment, acute toxoplasmosis treatment, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for toxoplasmosis treatment drugs. It also includes the market share of major companies in the toxoplasmosis treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Antiretroviral Therapy

[Research Material] Global Market for Antiretroviral Therapy

Global Market for Antiretroviral Therapy: NNRTI, NRTI, Multi-class Combination Products, Integrase Inhibitors, Hospitals, Clinics ...

This research report (Global Antiretroviral Therapy Market) investigates and analyzes the current state and outlook for the global antiretroviral therapy market over the next five years. It includes information on the overview of the global antiretroviral therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the antiretroviral therapy market include NNRTI, NRTI, multi-class combination products, and integrase inhibitors, while the segments by application focus on hospitals, clinics, and others. The regional segments calculate the market size for antiretroviral therapy by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the antiretroviral therapy sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.